ParcelBio
PrivateLast Round
Seed
May 7, 2026
Total Funding Raised
$14M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ParcelBio is a biotechnology company developing a new class of potent and durable mRNA medicines through its proprietary APEXm platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ParcelBio Comparables
Compare ParcelBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ensoma | 78% | |
| AbbVie | 76% | |
| Chimeron Bio | 70% |
ParcelBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 7, 2026 | ||||
| Seed Round | Mar 4, 2026 | ||||
| Seed | May 9, 2024 | ||||
| Pre Seed | Feb 1, 2024 |
ParcelBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Seed |
| Lexi Ventures | Seed |
| Pioneer Fund | Pre Seed |
| Ritual Capital | Seed, Seed Round |
| SBXi | Seed |
| Metaplanet Holdings | Seed |
| Surge Point Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2026
$13M round led by Breyer Capital.
- Mar 4, 2026
$13.17M raised in Seed Round.
ParcelBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ParcelBio's valuation, stock price, and market status.
Is ParcelBio a public or private company?
ParcelBio is a private company.
What is the current stock price of ParcelBio?
ParcelBio is a private company with no public stock price. No recent secondary market data is available.
How much is ParcelBio worth (valuation)?
Valuation information for ParcelBio is not publicly available.
Can I buy ParcelBio stock?
ParcelBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ParcelBio's last funding round?
ParcelBio's most recent funding round was Seed on May 7, 2026.
Who are the main investors in ParcelBio?
Key investors in ParcelBio include Breyer Capital.
Will ParcelBio IPO soon?
No public IPO plans have been announced for ParcelBio.
How can I track ParcelBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ParcelBio's secondary market activity and sign up for updates.